Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Eclinicalmedicine|June 8, 2023
Effect of the relationship between anaemia and systemic inflammation on the risk of incident tuberculosis and death in people with advanced HIV: a sub-analysis of the REMEMBER trialMariana Araújo-Pereira, Sonya Krishnan, Padmini Salgame, et al.
Viruses|June 26, 2026
Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined ScenariosRobert W Shafer, Kaiming Tao, Tom Loosli, et al.
The Lancet. HIV|June 11, 2026
Guidance on the clinical management of HIV-1 persistent low-level viraemia on antiretroviral treatment: a scoping review and an international Delphi consensusTommaso Clemente, Arjen J Stam, Olof Elvstam, et al.
Plos Medicine|December 5, 2018
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trialCissy Kityo, Alexander J Szubert, Abraham Siika, et al.
The New England Journal of Medicine|July 12, 2014
Assessment of second-line antiretroviral regimens for HIV therapy in AfricaNicholas I Paton, Cissy Kityo, Anne Hoppe, et al.
Contemporary Clinical Trials|January 9, 2026
Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan AfricaDiana Anena, Elizabeth Chappell, Rashidah Nazzinda, et al.
Gene Therapy|September 8, 2021
Towards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)Jennifer E Adair, Lindsay Androski, Lois Bayigga, et al.
Pathogens & Immunity|October 27, 2025
Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025Kiho Tanaka, Tatenda Jimmy Blessing Chikowore, Steven G Deeks, et al.
BMJ Open Respiratory Research|August 11, 2021
Efficacy of convalescent plasma for treatment of COVID-19 in UgandaBruce Kirenga, Pauline Byakika-Kibwika, Winters Muttamba, et al.
The Lancet. Child & Adolescent Health|January 24, 2026
Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trialAnna Turkova, Ellen White, Avy Violari, et al.
Pageof 20